Description:
As a highly educated science expert, you’re developing the next best medical breakthrough. Yet, if you don’t spend time raising money, managing that money, developing a commercialization plan and thinking about global markets, you will fail in the long run. Thinking about the business side of development can set you up for success long term. Come hear a panel of experts speak on successfully creating a vision and plan to master the business side of the science. Learn about:
Understanding the key components of a practical strategic plan
Performing the right business due diligence to align with your science
Creating a personalize success path
Raising the right money at the right time
Dodging painful mistakes
Who should attend: Early-stage entrepreneurs, investors, and business development professionals in life sciences.
Panelists:
Kristin King, Member/Investor Boston Harbor Angels
Kristin King is an experienced biotech exec, serial intrapreneur, investor and strategic advisor to startups developing biotech solutions. Starting her career designing stents, a patent inventor for JnJ’s drug eluting stent, and progressing through marketing, strategic, and commercial leadership roles she has contributed to some of the world’s most meaningful programs at top biotech firms including Ansell Healthcare, Becton Dickinson, Johnson & Johnson, Abbott Vascular, and Pfizer. She has an MBA from NYU Stern in Marketing & Finance, and a BS in Bioengineering & Math from Syracuse. Kristin is a high energy leader, passionate about helping teams to advance healthcare solutions.
Jason Kraus, Venture Capital Investor; Startup Consultant and Advisor; Entrepreneur; 20k+ connections
Jason Kraus serves as a partner in the EQx Fund, specializing in deal flow. He has experience in the venture arm of a private family office and as a member for the Boston Harbor Angels. Jason founded a startup advisory firm, Prepare 4 VC, to coach entrepreneurs through the fundraising process and create more powerful pitches. He is also a co-founder of commercial real estate and early stage investment firm Equity Venture Partners
Jack Malley, Partner at Rucci, Bardaro & Falzone, PC
Jack Malley founded and was managing partner of Jensen & Malley Company, a Waltham-based business consulting firm formerly associated with Malley & Franey Financial Group, before the company was acquired by RBF in February 2016. As the partner in charge of RBF’s OASYS Group, he specializes in financial systems and operational consulting. He is an expert at assisting start-ups, investors, specialty lenders and established private and public companies in various stages of growth. Jack received his BA in economics from the College of the Holy Cross, and his MBA in accounting and finance from Northeastern University.
Tony Martignetti, Leadership Coach, Inspired Purpose Coaching
Tony Martignetti is a leadership coach with a specialty in working with leaders and their teams to navigate through change and unlock their true potential. Tony supports leaders in gaining clarity so they can make better decisions, improve their leadership skills and ultimately increase their impact. Before sharing his experience as a coach, Tony was a finance and strategy professional with experience working with some of the world’s leading life sciences companies including Genzyme Corporation, Vertex Pharmaceuticals and Sarepta Therapeutics.
Wendy Pease, President, Rapport International
Wendy Pease is owner of Rapport International, a company that eliminates spoken and written language barriers around the world by offering written translation, spoken interpretation, transweblation, keyword and brand name testing, global communications consulting in 200+ languages. Prior to this, she served in corporate senior management positions in international marketing and business development, including roles at PAREXEL and Biogen. She has an MBA from Dartmouth College, and a BA in Foreign Service from Penn State. Wendy has lived in Mexico, Taiwan and the Philippines and is passionate about languages, cultures and communications.